McKinsey Settles $650 Million Over Role in OxyContin Sales: A Landmark Case in the Opioid Crisis
McKinsey & Company, one of the world’s most prestigious consulting firms, has agreed to a $650 million settlement with the U.S. Department of Justice (DOJ) for its role in boosting the sales of OxyContin, Purdue Pharma’s controversial opioid. According to court documents filed on Friday in Virginia, this settlement allows McKinsey to avoid criminal prosecution […]